Navinta Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NAVINTA LLC, and what generic and branded alternatives to NAVINTA LLC drugs are available?
NAVINTA LLC has sixteen approved drugs.
Summary for Navinta Llc
US Patents: | 0 |
Tradenames: | 15 |
Ingredients: | 15 |
NDAs: | 16 |
Drug Master File Entries: | 25 |
Drugs and US Patents for Navinta Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Navinta Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 078601-003 | Jul 17, 2014 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Navinta Llc | NICARDIPINE HYDROCHLORIDE | nicardipine hydrochloride | INJECTABLE;INJECTION | 090125-001 | Nov 17, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Navinta Llc | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | INJECTABLE;INJECTION | 202938-001 | Mar 28, 2013 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Navinta Llc | INDOMETHACIN SODIUM | indomethacin sodium | INJECTABLE;INJECTION | 206561-001 | Jul 19, 2017 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Navinta Llc | FOMEPIZOLE | fomepizole | INJECTABLE;INJECTION | 078537-001 | Mar 6, 2008 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Navinta Llc | CARGLUMIC ACID | carglumic acid | TABLET, FOR SUSPENSION;ORAL | 213395-001 | Jun 22, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.